A broncofibroscopia no diagnóstico etiológico de afecções pulmonares em pacientes com síndrome da imunodeficiência adquirida

Revista da Associação Médica Brasileira (Impact Factor: 0.92). 01/2000; DOI: 10.1590/S0104-42302000000200012
Source: DOAJ

ABSTRACT OBJETIVO: Avaliar o papel da broncofibroscopia no diagnóstico etiológico de pneumopatias em pacientes positivos ao vírus da imunodeficência humana. MÉTODOS: O presente estudo analisa um grupo de 49 pacientes com diagnóstico de síndrome da imunodeficiência adquirida, admitidos no Hospital Nereu Ramos - Florianópolis -SC. Foram selecionados pacientes sintomáticos respiratórios com lesão simples ao exame radiográfico do tórax, sem diagnóstico etiológico confirmado por exame de escarro. Tais pacientes foram submetidos à broncofibroscopia com realização de lavado broncoalveolar, escovado brônquico e biópsia pulmonar transbrônquica. As amostras foram analisados com bacterioscopia pelo Gram, pesquisa de BAAR, citomegalovírus, P. carinii e outros fungos. RESULTADOS: A broncofibroscopia foi efetiva na realização do diagnóstico etiológico em 71,43% dos casos. A biópsia pulmonar transbrônquica foi a técnica com maior positividade, firmando o diagnóstico em 59,18% dos casos. A técnica com menor positividade foi o escovado brônquico, com diagnóstico em 4,08% dos casos. O agente etiológico mais freqüente foi o P. carinii (42,8%), seguido pelo M. tuberculosis (22,86%). Nenhuma complicação foi observada nos procedimentos realizados. CONCLUSÃO: Concluímos no presente estudo que neste grupo de pacientes a broncofibroscopia foi um procedimento seguro e efetivo para o diagnóstico etiológico de afecções pulmonares.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The clinical records and autopsy data of 75 patients dying with AIDS were reviewed to determine the frequency of individual diseases diagnosed premortem and postmortem, the significance of pulmonary processes found in the lungs at autopsy, and the clinical and pathologic causes of death. Cytomegalovirus (CMV) infection was identified histologically either premortem or postmortem in 81% of patients. The lungs and adrenal glands were infected most commonly. Only one-half of CMV infections were recognized premortem. Pneumocystis pneumonia and Kaposi sarcoma occurred in 68% and 59% of patients, respectively, but were not unsuspected premortem in any patient. Visceral involvement with Kaposi sarcoma, however, was frequently recognized only at autopsy. While disseminated M. avium-intracellulare infection was common (31% of patients), histologically documented pulmonary disease was uncommon (3% of patients). Cryptococcal infection, diagnosed in 10 patients, was confined to the central nervous system in only 1 patient. Toxoplasma, in contrast, infected the brain of only 6 patients. All 75 patients had one or more disease processes identified in their lungs or pleurae at autopsy. These processes included opportunistic infections in 76% of patients, neoplasms in 37% (Kaposi sarcoma in 36% and lymphoma in 3%), and other processes in 60%. The most prevalent pathogen, CMV was found in pulmonary tissue from 44 patients and caused significant disease in 21 patients. Five patients died due to CMV pneumonia. Pneumocystis carinii was found at autopsy in 24 patients. In spite of treatment, pneumocystis pneumonia was fatal in 11 patients. One patient died with concomitant CMV and pneumocystis pneumonia. Kaposi sarcoma, identified in the lungs of 23 patients, led to death in 5 patients via upper airway obstruction, hemorrhage, or parenchymal destruction. Other fatal pulmonary processes included bacterial pneumonia in 9 patients, idiopathic diffuse alveolar damage in 5, cryptococcosis in 2, and pulmonary hemorrhage in 1. Specific clinical criteria were used to determine the cause of death due to organ system failure. Fifty-one percent of patients died due to respiratory failure; 16% from neurologic disease; 17% from hypotension that was not caused by respiratory, neurologic, or cardiac disease; and 3% from cardiac dysfunction. Thirteen percent of deaths did not meet the clinical criteria defining these 4 categories. This clinical assessment was combined with autopsy data to identify specific diseases as causes of death.(ABSTRACT TRUNCATED AT 400 WORDS)
    Medicine 10/1991; 70(5):326-43. · 4.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Over a four-year period, 130 patients with the acquired immune deficiency syndrome were studied to assess the incidence and spectrum of pulmonary disease associated with this illness. In 61 patients (47 percent), respiratory abnormalities were either present on admission or later developed. Multiple pathologic processes were present simultaneously in 24 patients and serial pulmonary problems developed in seven patients. Infection was the most common cause of pulmonary parenchymal disease and was due to Pneumocystis carinii (35 patients), cytomegalovirus (21 patients), Mycobacterium avium-intracellulare (13 patients), and bacteria (four patients). Noninfectious causes of parenchymal lung diseases were also frequently seen and included Kaposi's sarcoma (eight patients), non-specific pneumonitis (seven patients), and adult respiratory distress syndrome (four patients). Significant pleural disease was present in six cases and was usually related to Kaposi's sarcoma. A bronchospastic disorder developed in four patients. Pulmonary function tests, in particular the diffusing capacity and the difference between rest and exercise alveolar-arterial oxygen tension, were helpful in screening for pulmonary diseases. Patterns of clinical features and radiographic abnormalities were recognized and suggested specific diagnoses. Overall mortality from respiratory causes identified during the study was 41 percent, but varied markedly with the etiologic agent. Respiratory failure, however, carried a 100 percent mortality despite the underlying cause.
    The American Journal of Medicine 04/1985; 78(3):429-37. · 5.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effectiveness of fiberoptic bronchoscopy with the addition of bronchoalveolar lavage (BAL) was evaluated in 72 patients with the acquired immune deficiency syndrome (AIDS) and parenchymal pulmonary disease. The diagnostic yield varied for different pathogens and was 94% (45/48 cases) for Pneumocystis carinii, 67% (14/21 cases) for cytomegalovirus, and 62% (8/13 cases) for Mycobacterium avium intracellulare. Of the 11 cases of documented Kaposi's sarcoma in the lung parenchyma, none were diagnosed from bronchoscopy, although characteristic endobronchial lesions were seen in 6 cases. Overall, the yield of bronchoscopy for all pathogens was 65%. Both transbronchial biopsy and BAL had high independent yields (88 and 85%, respectively) for diagnosing P. carinii pneumonia but combining the procedures gave the best yield. Cytomegalovirus was most often diagnosed from examination and culture of the BAL. Recovery of Mycobacterium avium intracellulare was highest with culture of both washings and lavage. Neither granuloma nor organisms were seen on examination of histologic specimens. Bronchoscopy with BAL was well tolerated with few complications even in 5 patients with thrombocytopenia and 10 patients requiring mechanical ventilation. Sixteen patients (22%) had an increase in temperature after the procedure without hypotension or sepsis and 1 patient (1.5%) had a moderate pulmonary hemorrhage after transbronchial biopsy. Fiberoptic bronchoscopy with BAL is a safe procedure with a high diagnostic yield in AIDS patient with lung disease.
    The American review of respiratory disease 11/1984; 130(4):659-62. · 10.19 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014